Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BlackBerry Ltd T.BB

Alternate Symbol(s):  BB

BlackBerry Limited is a Canada-based company, which provides intelligent security software and services to enterprises and governments worldwide. The Company leverages artificial intelligence (AI) and machine learning to deliver solutions in the areas of cybersecurity, safety, and data privacy and specializes in the areas of endpoint management, endpoint security, encryption, and embedded systems. It operates in three segments: Cybersecurity, IoT, and Licensing and Other. Cybersecurity consists of BlackBerry UEM and Cylance cybersecurity solutions (collectively, BlackBerry Spark), BlackBerry AtHo, and BlackBerry SecuSUITE. The Company’s endpoint management platform includes BlackBerry UEM, BlackBerry Dynamics, and BlackBerry Workspaces solutions. The IoT consists of BlackBerry QNX, BlackBerry Certicom, BlackBerry Radar, BlackBerry IVY and other Internet of things (IoT) applications. Licensing and Other consists of the Company’s intellectual property arrangements and settlement award.


TSX:BB - Post by User

Bullboard Posts
Post by investorblingon Feb 21, 2007 1:34pm
179 Views
Post# 12280304

Recommendations for February 21, 2007 (Part 2)

Recommendations for February 21, 2007 (Part 2)

Concorde

Open Text Corporation | Peter Misek, OTEX : NNM : US$23.65 | $1,200.0M | Sell , Target US$20.00

Diminished growth prospects and overvalued price; lowering recommendation to Sell

Answers Corporation | Colin Gillis, ANSW : NNM : US$14.45 | $114.5M | Buy , Target US$20.00

DecQ results click with 182% growth; 2006 grew 242% over 2005

Avocent | Mark Kelleher, AVCT : NNM : US$34.59 | $1,760.0M | Buy , Target US$44.80

HP reports strong results

Research In Motion Ltd. | Peter Misek, RIMM : NNM : US$141.62 | $26,882.5M | Buy , Target US$180.00

Another strong showing for RIM in our February 2007 Global Handset Survey

CeNeS | Karl Keegan, CEN : AIM : 8.4p | £40.5M | Hold , Target 11p

M6G: equivocal Phase 3 results

Elan Corporation | Karl Keegan, ELN : ID : €10.90 | €5,904.0M | Sell, Target €7.74

Tysabri on track, but not enough

Vital Images | Matthew Scalo, VTAL : NNM : US$35.08 | $575.9M | Buy , Target US$38.00

Q4 in line; 2007 revenue guidance as expected; PT moves to $38

Hana Biosciences | Joseph Pantginis, Ph.D., HNAB : NNM : US$6.24 | $181.1M | Buy , Target US$11.00

Zensana formulation delay; we see no reason to fret

 

Bullboard Posts